New Model to Improve Clinical Success of Cancer Immunotherapies

Mainz, October 18, 2011 – Collaborative White Paper between the Mainz based Association of Cancer Immunotherapy (CIMT) and the Cancer Immunotherapy Consortium (CIC) of the Cancer Research Institute (CRI) in New York outlines new methodological framework to guide informed, reproducible success in cancer immunotherapy development.

Read more